, Tracking Stock Market Picks
Enter Symbol:
Pluristem Therapeutics Inc. (PSTI) [hlAlert]

Speculative Buy
down 21.68 %

Pluristem Therapeutics Inc. (PSTI) rated Speculative Buy with price target $5 by Global Hunter Securities

Posted on: Friday,  Dec 9, 2011  10:25 AM ET by Global Hunter Securities

Global Hunter Securities rated Speculative Buy Pluristem Therapeutics Inc. (NASDAQ: PSTI) on 12/09/2011, when the stock price was $2.49.
Since then, Pluristem Therapeutics Inc. has lost 21.69% as of 12/22/2015's recent price of $1.95.
If you would have followed this Global Hunter Securities's recommendation on PSTI, you would have lost 21.68% of your investment in 1474 days.

Pluristem Therapeutics Inc. is a bio-therapeutics company engaged in developing and intending to commercialize, cell therapy production technologies and products. The Company focuses on commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several degenerative, ischemic and autoimmune disorders. It is developing a pipeline of products, stored ready to use, that are derived from human placenta, a non-controversial, non-embryonic adult stromal cell source. The Company?s focuses in the development of product candidates for local administration for indications, such as Peripheral artery disease (PAD), Critical limb ischemia (CLI), intermittent claudication, neuropathic pain, wound healing and orthopedic injuries. The Company focuses on developing Placenta expanded cells- peripheral artery disease (PLX-PAD) cells as an allogeneic therapeutic product to treat CLI which results from PAD.

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/9/2011 10:25 AM Buy
2.49 5.00
as of 12/30/2011
1 Week down  -1.96 %
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy